Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-11-18FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for fluphenazine hydrochloride (generic) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2008-11-13Clinical Trial Update: Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia
A clinical trial update on developing population norms for a computerized neuropsychological assessment used to evaluate the effectiveness o…
-
CLINICAL_TRIALS research · 2008-11-11Clinical Trial Update: Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
This clinical trial update examines plasma levels of glutamatergic amino acids and oxytocin before and after neuroleptic treatment in patien…
-
CLINICAL_TRIALS trial_result · 2008-11-04Clinical Trial Update: Quality of Life (QOL) in Female Patient With Schizophrenia [Phase 4]
A Phase 4 clinical trial update from Inje University evaluating quality of life in a female patient with schizophrenia. The study status is …
-
CLINICAL_TRIALS trial_result · 2008-11-04Clinical Trial Update: Bone Density in Patients With Schizophrenia
A completed clinical trial investigating bone density in patients with schizophrenia, including individuals with alcohol use disorders, has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-10-30FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for HALOPERIDOL DECANOATE from Fresenius Kabi USA, LLC.
-
FDA approval · 2008-10-30FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for haloperidol lactate from Fresenius Kabi USA, LLC, validating the generic product HALOPERIDOL LAC…
-
FDA approval · 2008-10-30FDA Approved: RISPERIDONE — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's original application for risperidone, providing a generic version of the antipsychotic.
-
CLINICAL_TRIALS trial_result · 2008-10-29Clinical Trial Update: Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluating adjunctive aripiprazole in clozapine-treated patients with refractory schizophrenia has completed.
-
FDA approval · 2008-10-16FDA Approved: RISPERIDONE — Original Application (Zydus Lifesciences Limited)
FDA approved an original abbreviated new drug application for risperidone by Zydus Lifesciences Limited, enabling the sale of a generic risp…
-
FDA approval · 2008-10-08FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, indicating an approved addition or …
-
CLINICAL_TRIALS trial_result · 2008-10-06Clinical Trial Update: Seroquel Long-Term NIS for Schizophrenia Patients
Completion of a long-term non-interventional study of quetiapine (Seroquel) in patients with schizophrenia and schizoaffective disorder has …
-
CLINICAL_TRIALS trial_result · 2008-10-02Clinical Trial Update: A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia [Phase 1]
Phase 1 study update on adjunctive treatment for cognitive deficits in schizophrenia; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-29Clinical Trial Update: Energy Homeostasis Under Treatment With Atypical Antipsychotics [Phase 4]
Phase 4 clinical trial update evaluating energy homeostasis in schizophrenia patients treated with atypical antipsychotics. The study status…
-
CLINICAL_TRIALS trial_result · 2008-09-26Clinical Trial Update: Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness
Three-year follow-up results from a randomized controlled trial of an intervention for tobacco dependence in individuals with a psychotic il…
-
CLINICAL_TRIALS trial_result · 2008-09-19Clinical Trial Update: A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain [Phase 2]
Phase 2 study evaluating the efficacy and safety of mifepristone to prevent olanzapine-induced weight gain has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-16Clinical Trial Update: Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy [Phase 4]
Phase 4 clinical trial investigating pharmacological therapy to modulate regional brain activation in schizophrenia was terminated.
-
FDA approval · 2008-09-08FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's supplemental application for LOXAPINE (LOXAPINE) under ANDA 072206. The action constitutes a supplemental appr…
-
FDA approval · 2008-09-08FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application from Actavis Pharma, Inc. for LOXAPINE (loxapine), establishing a generic loxapine product.
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Amisulpride in Schizophrenic Acute Phase Patients [Phase 4]
Phase 4 clinical trial update showing completion of a study evaluating amisulpride in the acute phase of schizophrenia.
-
FDA approval · 2008-08-26FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2008-08-26Clinical Trial Update: Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder [NA]
A completed clinical trial evaluating the effects of risperidone and olanzapine in patients with schizophrenia, schizoaffective disorder, ma…
-
CLINICAL_TRIALS trial_result · 2008-08-22Clinical Trial Update: Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol [Phase 4]
Phase 4 trial comparing the efficacy and tolerability of flunarizine versus haloperidol in schizophrenia, reporting on comparative effective…
-
FDA approval · 2008-08-19FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Fluphenazine Decanoate submitted by Mylan Institutional LLC. Fluphenazine Decanoate is a long-ac…
-
FDA approval · 2008-08-19FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for trifluoperazine hydrochloride from Mylan Pharmaceuticals Inc., authorizing changes described…